Bausch + Lomb Micronizes Lutein, Zeaxanthin In PreserVision OCUSorb
Analysts: No Small Impact On B+L Credit Rating From Bausch Health Continued Ownership
PreserVision AREDS 2 mini-softgel has proprietary OCUSorb formulation with micronized ingredients in a medium-chain triglyceride oil. More than line extensions, though, are needed for B+L to shed influence from Bausch Health’s credit rating.
You may also be interested in...
“Multi-year plan with three phases, all with measurable, clear objectives” starts with “rewire company for optimal performance” before moving to “innovate and execute” and then to “accelerate growth,” CEO says.
“What Sight Inspires You” campaign features stories and sights from B+L’s SightMatters online resource for people living with AMD, along with educational content on the condition including developing plans to help reduce risk of progression.
Demand for OTC pain relievers and cough/cold products jumped prior to October-December and remained high during quarter due to consumer concern not only about flu but also RSV and additional COVID-19 mutation. US and Canadian firms marketing OTC drugs and supplements also will be offering additional signals on planned spinoffs of consumer health businesses.